Table 2.
Bioactive Compound | Doses | In Vitro/ In Vivo/ Clinical Study |
Model | Bioactive Effect | References |
---|---|---|---|---|---|
EGCG and GSE | in vitro | cell culture of Caco-2 cells MEL cell culture mouse erythroleukemia (MEL) cell line |
↓transepithelial heme iron transpor ↑ apical heme iron uptake (GSE) ↓ the cellular assimilation of heme (EGCG) |
[83] | |
EGCG and GSE | in vitro | human Caco-2 (HTB-37TM) cell line murine erythroleukemia (MEL) cell line |
↓heme iron absorption by reducing the basolateral iron export in Caco-2 cells | [108] | |
Curcumin | 0.5% and 2.0% |
in vivo | FVB mice treated with curcumin for 12 weeks | ↓ in the H and L subunits of the iron storage protein ferritin ↑ transferrin receptor 1 ↑ activated iron-regulatory proteins (IRPs) ↓ in levels of ferritin in the liver |
[88] |
Curcumin | 0.2%, 0.5%, and 2.0% |
in vivo | C3H/HeNCrlmice AIN93M basal diet modified to contain various amounts of iron and curcumin: 5, 12, 50, or 1000 mg iron/kg diet plus curcumin at 0% (control), 0.2%, 0.5%, and 2.0% (wt/wt) for 26 weeks |
↓ HTC, Hb, serum iron, and transferrin saturation ↓ iron levels in the bone marrow and spleen -appearance of hypochromic RBCs ↑ transferrin receptor 1 (TfR1) ↑ iron-responsive element-binding protein (IRP) ↓ ferritin ↓ hepcidin |
[89] |
Silybin | in vitro | -iron chelating role -high affinity for ferric ion -binds Fe(III) even at acidic pH |
[105] | ||
Silybin | 140 mg silybin (Legalon Forte) | clinical study | patients with hereditary haemochromatosis | ↓ postprandial iron absorption | [106] |
Quercetin | 100 mg/kg body weight | in vivo in vitro |
ethanol-induced iron overload and liver damage in mice mouse primary hepatocytes |
-attenuated the hepatic iron deposition in mice exposed to ethanol or excess iron -prevented ethanol induced hepatic iron overload by regulating hepcidin expression via the BMP6/SMAD4 signaling pathway |
[109] |
Myrecitin | in vitro | HepG2 an HEK293 cells | ↓ HAMP mRNA levels ↓SMAD1/5/8 phosphorylation |
[103] | |
Myrecitin | 40-mg/kg myricetin daily for 1 or 5 days 10-mg/kg myricetin for 5 days, after which the mice were injected with LPS (5 mg/kg, ip) 0.2% (w/w) myricetin for up to 30 days |
in vivo | C57BL/6 mice | ↓ hepatic hepcidin expression ↓ splenic iron levels ↑ serum iron levels ↑ red blood cell counts ↑ Hb |
[103] |
Black soybean seed coat anthocyanins extract (BSSCE) | 200 mg/mL BSSCE 2% BSSCE |
in vitro in vivo |
AIN-76A diet containing 2% BSSCE feeded to 8-week-old male C57BL/6 mice for 0, 1, 7, 15 or 30d | ↓ hepcidin expression ↓ splenic Fe concentrations ↑ serum Fe concentrations ↑ in erythrocyte counts, Hb concentrations, HTC values |
[110] |
Citrus flavonoids-rich extracts from bergamot and orange juices |
in vitro | iron overloaded human lung epithelial cells basal epithelial cell line A549, derived from human lung carcinoma |
↓ ROS ↓ lipid peroxidation ↑mitochondrial function ↑ iron chelation -prevented DNA-oxidative damage in iron-exposed cells ↑ catalase activity |
[111] | |
Baicalein (Scutellaria baicalensis) | in vitro | -induced iron chelation -inhibition of iron-mediated Fenton reaction via a combination of chelation and radical scavenging mechanism |
[112] | ||
Genistein | in vivo in vitro |
-zebrafish embryo (Danio rerio) -the human hepatocarcinoma cell line, HepG2 |
↑ hepcidin expression and promoter activity in zebrafish and human hepatocytes in a STAT3- dependent and SMAD4-dependent manner | [113] | |
Vitamin C | 50 and 100 mg/mL | in vivo | hepcidin-producing HepG2 cell line | -inhibition of hepcidin expression | [114] |
Tucum-Do-Cerrado (Bactris setosa Mart.) | AIN-93G diet with 150 g of tucum-do-cerrado fruit (pulp and peel)/kg diet iron-supplemented rodent diet (350 mg of iron/kg diet) and 150 g of tucum-do-cerrado fruit/kg diet |
in vivo | Wistar rats | ↓ spleen lipid and protein oxidation; mRNA levels of hepatic Hamp and ferritin ↑ serum antioxidant capacity ↑ hepatic mRNA levels of BMP6, Hmox1, Nqo1, and Nrf2 -abrogated the liver Hamp iron-induced upregulation -prevented intestinal iron accumulation; hepatic lipid peroxidation; splenic protein damage ↑ of CAT, GR, and GSH-Px activity |
[115] |
Angelica sinensis polysaccharide (ASP) | ASP at 25, 50, and 100 mg kg−1 | in vivo | BALB/c mice inoculated with H22 tumor cells | ↓ hepcidin concentration in serum ↓ levels of serum IL-6 ↓ serum ferritin ↓ levels of serum Tf ↓ levels of serum TfR2 ↓ levels of serum TfR1 in the ASP 25 mg kg−1 treatment group |
[116] |
Hydro-alcoholic extract of Medicago sativa and Allium porrum | 200 and 400 mg/kg body weight | in vivo | iron-overloaded rats | ↓ serum ferritin ↓ serum iron level |
[117] |
Methanolic extract of Angel’s wings mushroom (Pleurotus porrigens) | 200 and 400 mg/kg/24 h | in vivo | iron-overloaded mice NMRI mice |
-chelation of excess iron ↓ in plasma Fe3+ content ↓ in the extent of necrotic hepatocytes, fibrous tissues, and pseudo-lobules |
[118] |
Methanol extract of Nerium indicum leaves | 50, 100, and 200 mg/kg b.w. | in vivo | iron-overloaded mice | -antioxidant and iron-chelating properties ↓ iron overload induced toxicity -normalized the levels of ALAT, ASAT, ALP, and bilirubin ↑ levels of SOD, CAT, GST, and nonenzymatic-reduced glutathione ↓ levels of lipid peroxidation, protein carbonyl, hydroxyproline ↓ liver iron |
[119] |
Emblica officinalis fruit extract |
50, 100, and 200 mg kg−1 body weight | in vivo | iron-overloaded Swiss albino mice | ↓ liver iron ↓ serum ferritin ↓ ALAT, ASAT, ALP, and bilirubin ↓ in lipid peroxidation, protein oxidation, and collagen |
[120] |
Gallic acid (GA) and methyl gallate (MG) isolated from Spondias pinnata bark extract | 2 and 4 mg/kg b.w. GA 2 and 4 mg/kg b.w. MG |
in vitro in vivo |
iron-overloaded Swiss albino mice | ↓ ALAT, ASAT, ALP, and bilirubin ↓ ROS in liver and spleen homogenate ↓ ferritin-bound iron SOD, CAT, GST, GSH restioration |
[121] |
Aqueous and 70% methanol extracts of Clerodendrum colebrookianum leaves |
50, 100 and 200 mg/kg body weight | in vitro in vivo |
iron-overloaded Swiss albino mice | ↓ liver iron ↓ serum ferritin ↓ ALAT, ASAT, ALP, and bilirubin SOD, CAT, GST, GSH restioration ↓ lipid peroxidation ↓ the protein carbonyl content |
[122] |
Methanol extract of Terminalia chebula Retz. fruit | 50, 100, 200 mg/kg b.w. | in vitro in vivo |
iron-overloaded Swiss albino mice | in vitro: iron chelation, and DNA protective effects in vivo: ↓ ALAT, ASAT, ALP, and bilirubin ↑ antioxidant acvtivity ↓ lipid peroxidation, protein carbonyl, hydroxyproline and liver iron ↓ iron overload-induced toxicity -potential activity for reductive release of ferritin iron |
[123] |
Baicalin and quercetin | in vitro in vivo |
iron-dextran induced iron overload mice | in vitro study: released iron from ferritin In vivo: -inhibited iron overload induced lipid peroxidation and protein oxidation of liver ↓ hepatic iron and hepatic collagen content ↑ the serum non-heme iron level but not serum ferritin level ↑ the excretion of iron through feces |
[124] | |
Mangiferin (M) and an aqueous leaf extract of Mangifera foetida L (EMF) | mangiferin 75 mg/kg EMF 2.930 g/kg |
in vivo | iron-overloaded Sprague Dawley rats | ↑ body weight ↓ plasma iron ↑ iron excretion via urine M and EMF antioxidant activity |
[125] |
EGCG (-), epigallocatechin-3-gallate; GSE, grape seed extract; MEL, mouse erythroleukemia; IRPs, iron-regulatory proteins; TfR1, transferrin receptor 1; IRP, iron-responsive element-binding protein; BSSCE, black soybean seed coat anthocyanins extract; VAD, vitamin A deficiency; IL-8, interleukin-8; ROS, reactive oxygen species; STAT3, signal transducer and activator of transcription 3; Tuc-AIN-93G added of tucum-do-cerrado; TucFe-AIN-93G with tucum-do-cerrado and iron-enriched; Hmox1, heme oxygenase 1; Nqo1, NADPH dehydrogenase quinone 1; Nrf2, factor nuclear factor-erythroid 2-related factor 2; GR, glutathione reductase; Tf, transferrin; TfR2, transferrin receptor 2; ALAT, alanine aminotransferase; ASAT, aspartate aminotransferase; ALP, alkaline phosphatase; GST, glutathione-S-transferase; GA, gallic acid; MG, methyl gallate; GSH, reduced glutathione; EMF, extract of Mangifera foetida L; HepG2, human hepatocellular carcinoma cells; HEK293, human embryonic kidney cells.